SELLAS (SLS) is a publicly traded Healthcare sector company. As of September 8, 2026, SLS trades at $14.15 with a market cap of $2.80B and a P/E ratio of -55.44. SLS moved +1.59% today. Year to date, SLS is +267.64%; over the trailing twelve months it is +625.65%. Its 52-week range spans $0.85 to $15.88. Analyst consensus is buy with an average price target of $27.50. Rallies surfaces SLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks SLS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $14.15 |
| Market Cap | $2.80B |
| P/E Ratio | -55.44 |
| EPS | $-0.25 |
| Dividend Yield | 0.24% |
| 52-Week High | $15.88 |
| 52-Week Low | $0.85 |
| Volume | 1.51M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.86M |
| Gross Margin | 0.00% |
2 analysts cover SLS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.50.